The demand for bone grafts and substitutes in USA is projected to grow from USD 1.3 billion in 2025 to USD 1.7 billion by 2035, at a CAGR of 2.9%. On-Body Injectors will dominate with a 22.4% market share, while oncology will lead the deployment mode segment with a 21.4% share.